

Improvement in time in range after smart pen initiation in routine clinical practice
In this medfyle
Real-world data show initiating a smart insulin pen for bolus insulin may be associated with a significant increase in time-in-range (TIR) and a significant decrease in time-below-range (TBR).
About this Medfyle
This is a summary of a presentation given at the EASD 2023 Annual Meeting. The content is developed by Infomedica in collaboration with the Diabetes Education Study Group (DESG).
The information and data provided is for information purposes only. The presenting author(s) of the original presentation had no involvement in the creation of this content. The viewpoints expressed may not represent Infomedica, Medfyle, or the DESG.
©2023 Infomedica-Medfyle. All rights reserved.